Transient Hyperglycemia in a Patient With Type 2 Diabetes After COVID-19 Messenger RNA Vaccination: A Case Report


Aniebietabasi Okon-Umoren • Sean Yaphe • Andrea Smith • Karla D. Passalacqua • Katarzyna Budzynska, Published: July 06, 2024, DOI: 10.7759/cureus.63983  Abstract The development of new vaccines against the SARS-CoV-2 virus in response to the COVID-19 pandemic represents a milestone…[...]

Covid infection associated with a greater likelihood of Type 2 diabetes, according to review of patient records


Authors: Lenny Bernstein - March 21, 2022 The Washington Post People who had covid-19 were at greater risk of developing Type 2 diabetes within a year than those who managed to avoid…[...]

SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment


aUTHORS: Chien-Ting Wu,1,13Peter V. Lidsky,2,13Yinghong Xiao,2,13Ivan T. Lee,3,4,5,13Ran Cheng,1,6,13Tsuguhisa Nakayama,5,7,13Sizun Jiang,3,13Janos Demeter,1Romina J. Bevacqua,8Charles A. Chang,8,9,10,11Robert L. Whitener,8Anna K. Stalder,12Bokai Zhu,3Han Chen,3 Cell Metab. 2021 Aug 3; 33(8): 1565–1576.e5.Published online 2021…[...]

Hyperglycemia in Acute COVID-19 is Characterized by Adipose Tissue Dysfunction and Insulin Resistance


Authors: Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V, Bram Y, Hoffman K, Rubio-Navarro A, Uhl S, Shukla AP, Goyal P, tenOever BR, Alonso LC, Schwartz RE, Schenck EJ, Safford MM Abstract  COVID-19 has proven to be a metabolic…[...]